Collectively, our data suggest that, perhaps in MASH-driven HCC, IL-21R plays a pro-tumorigenic inflammatory role and that blockade of IL-21R signaling will result in attenuated MASH-driven HCC development. The gene discussed is IL21R; the disease is hepatocellular carcinoma.